1. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials;Pincus;J Rheumatol,2008
2. Composite versus individual measures of disease activity in rheumatoid arthritis [editorial];Neogi;J Rheumatol,2008
3. Clinical judgment in rheumatoid arthritis. II. Judging 'current disease activity' in clinical practice.
4. Judgment of âcurrent disease activityâ in rheumatoid arthritis â an international comparison;Kirwan;J Rheumatol,1983
5. Measuring physiciansâ judgement â The use of clinical data by Australian rheumatologists;Kirwan;Aust NZ J Med,1985